People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fio Corp | — | Biotechnology | Series A | $10.5M | $299.4M | 2010 |
Shlomit Mordinson Dekel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shlomit Mordinson Dekel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert M. Friedland | 1 | 4 |
| Kerri Mordinson Reid | 1 | 1 |
| Michael Mordinson Greenberg, MD | 1 | 1 |
| Michael Mordinson Greenberg | 1 | 1 |
| Kerri M. Reid | 1 | 1 |
| Robert Mordinson Friedland | 1 | 1 |
| Michael Mordinson Craig | 1 | 1 |
| R. Michael Craig | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.